Skip to content

Clinical trials

Completed Phase 3 Chronic Limb-Threatening Ischemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Limb-Threatening Ischemia Phase: Phase 3 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20131
20171
20181
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Northland Biotech. Co., Ltd.2
Boston Scientific Corporation1
Harvest Technologies1
Mahidol University1
Pluristem Ltd.1
Sanofi1
Vericel Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Limb-Threatening Ischemia8
Peripheral Vascular Diseases4
Arterial Occlusive Diseases2
Ischemia2
Peripheral Arterial Disease2
Ulcer2
Atherosclerosis1
Gangrene1
Leg Ulcer1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.